Infinity Reviews 2006 Achievements and Announces Product and (Reverse lookup)
MSN MoneyCentral - * Published evidence of biological activity of IPI-504, Infinity's lead anticancer agent, in a Phase I clinical trial in patients with gastrointestinal stromal tumors (GIST) * Completed a reverse merger with Discovery Partners International, Inc
